Cresco Labs Inc (CRLBF)
1.988
+0.04
(+1.95%)
USD |
OTCM |
Apr 26, 10:56
Cresco Labs Enterprise Value: 988.90M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 988.90M |
| April 24, 2024 | 1.026B |
| April 23, 2024 | 1.009B |
| April 22, 2024 | 999.09M |
| April 19, 2024 | 1.006B |
| April 18, 2024 | 1.040B |
| April 17, 2024 | 1.070B |
| April 16, 2024 | 1.023B |
| April 15, 2024 | 1.006B |
| April 12, 2024 | 1.006B |
| April 11, 2024 | 1.057B |
| April 10, 2024 | 1.064B |
| April 09, 2024 | 1.104B |
| April 08, 2024 | 1.108B |
| April 05, 2024 | 1.087B |
| April 04, 2024 | 1.030B |
| April 03, 2024 | 1.091B |
| April 02, 2024 | 1.067B |
| April 01, 2024 | 1.087B |
| March 28, 2024 | 1.030B |
| March 27, 2024 | 1.084B |
| March 26, 2024 | 1.020B |
| March 25, 2024 | 1.008B |
| March 22, 2024 | 1.060B |
| March 21, 2024 | 1.074B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.030B |
| March 19, 2024 | 1.023B |
| March 18, 2024 | 1.047B |
| March 15, 2024 | 968.52M |
| March 14, 2024 | 899.66M |
| March 13, 2024 | 934.55M |
| March 12, 2024 | 856.42M |
| March 11, 2024 | 842.83M |
| March 08, 2024 | 859.81M |
| March 07, 2024 | 849.62M |
| March 06, 2024 | 859.81M |
| March 05, 2024 | 900.58M |
| March 04, 2024 | 876.65M |
| March 01, 2024 | 907.37M |
| February 29, 2024 | 914.17M |
| February 28, 2024 | 927.76M |
| February 27, 2024 | 931.15M |
| February 26, 2024 | 975.31M |
| February 23, 2024 | 1.006B |
| February 22, 2024 | 954.93M |
| February 21, 2024 | 900.58M |
| February 20, 2024 | 917.56M |
| February 16, 2024 | 915.08M |
| February 15, 2024 | 954.93M |
| February 14, 2024 | 941.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
492.58M
Minimum
Mar 18 2020
4.023B
Maximum
Feb 10 2021
1.550B
Average
1.253B
Median
Jul 16 2020
Enterprise Value Benchmarks
| Flora Growth Corp | 14.04M |
| Tilray Brands Inc | 1.516B |
| Clever Leaves Holdings Inc | 1.182M |
| Seelos Therapeutics Inc | 15.12M |
| Skye Bioscience Inc | 363.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.635M |
| Revenue (Quarterly) | 188.24M |
| Total Expenses (Quarterly) | 161.17M |
| EPS Diluted (Quarterly) | 0.0143 |
| Gross Profit Margin (Quarterly) | 51.08% |
| Profit Margin (Quarterly) | 1.40% |
| Earnings Yield | -26.95% |
| Operating Earnings Yield | 9.77% |
| Normalized Earnings Yield | -6.002 |